Immunization, HepB3 in Upper middle income
Upper middle income: Immunization, HepB3 was 88.0% in 2024. ◆ Volatile
Immunization, HepB3 in Upper middle income, 1985–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
In 2024, immunization, hepb3 in Upper middle income stood at 88.0%.
That represents a change of down 1.1% on the previous year and down 4.7% over ten years.
Over the whole period, immunization, hepb3 in Upper middle income peaked at 93.4% in 2009 and was at its lowest, 0.0%, in 1985.
Upper middle income ranks 14th of 47 groups on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, HepB3 in Upper middle income, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1985 | 0.0% | — |
| 1986 | 0.0% | — |
| 1987 | 0.0% | — |
| 1988 | 0.0% | — |
| 1989 | 0.6% | — |
| 1990 | 0.8% | +24.9% |
| 1991 | 0.8% | +4.8% |
| 1992 | 3.7% | +350.0% |
| 1993 | 6.7% | +78.3% |
| 1994 | 10.2% | +52.3% |
| 1995 | 15.7% | +53.8% |
| 1996 | 18.0% | +15.0% |
| 1997 | 20.5% | +13.7% |
| 1998 | 21.5% | +5.0% |
| 1999 | 28.9% | +34.5% |
| 2000 | 59.5% | +105.8% |
| 2001 | 63.2% | +6.1% |
| 2002 | 66.9% | +5.9% |
| 2003 | 74.9% | +11.8% |
| 2004 | 79.3% | +6.0% |
| 2005 | 83.2% | +4.9% |
| 2006 | 87.5% | +5.2% |
| 2007 | 89.1% | +1.8% |
| 2008 | 91.4% | +2.6% |
| 2009 | 93.4% | +2.1% |
| 2010 | 92.8% | -0.7% |
| 2011 | 93.0% | +0.2% |
| 2012 | 93.4% | +0.4% |
| 2013 | 91.6% | -2.0% |
| 2014 | 92.4% | +0.9% |
| 2015 | 91.5% | -1.0% |
| 2016 | 91.9% | +0.5% |
| 2017 | 90.9% | -1.1% |
| 2018 | 90.6% | -0.3% |
| 2019 | 89.9% | -0.8% |
| 2020 | 88.9% | -1.1% |
| 2021 | 85.7% | -3.6% |
| 2022 | 90.6% | +5.7% |
| 2023 | 89.1% | -1.7% |
| 2024 | 88.0% | -1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 0.1% | 0.0% | 0.6% | 5 |
| 1990s | 12.7% | 0.8% | 28.9% | 10 |
| 2000s | 78.8% | 59.5% | 93.4% | 10 |
| 2010s | 91.8% | 89.9% | 93.4% | 10 |
| 2020s | 88.5% | 85.7% | 90.6% | 5 |
More health data for Upper middle income
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 70-74, male, annual growth rate 4.65 % change on previous year (2025)
- Population ages 70-74, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 70-74, male, per capita 0.0158 units per person (2025)
- Population ages 75-79, female, annual growth rate 7.83 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0122 units per person (2025)
- Population ages 75-79, male, annual growth rate 7.18 % change on previous year (2025)
- Population ages 80 and above, male, annual growth rate 3.32 % change on previous year (2025)
- Population ages 80 and above, female, per capita 0.0129 units per person (2025)
Frequently asked questions
- What is immunization, hepb3 in Upper middle income?
- Immunization, hepb3 in Upper middle income was 88.0% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in Upper middle income?
- The highest recorded value was 93.4% in 2009.
- What is the lowest immunization, hepb3 recorded in Upper middle income?
- The lowest recorded value was 0.0% in 1985.
- How does Upper middle income rank for immunization, hepb3?
- Upper middle income ranks 14th out of 47 groups with data for 2024.
- Is immunization, hepb3 rising or falling in Upper middle income?
- Over the last ten years it is down 4.7%. The long-run trend across the full record is volatile.
- Where does this Upper middle income data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 40 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.